Bionote pushes back $200m KRX IPO
Timing changes but the Koran diagnostics firm's deal size to remain the same
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
Bionote pushes back $200m KRX IPO